comparemela.com

Latest Breaking News On - Sharvil patel - Page 8 : comparemela.com

Torrent and Zydus sign pact to co-market Saroglitazar for chronic liver diseases in India

Torrent, Zydus collaborate to bring liver disease treatment to India

Torrent, Zydus collaborate to bring liver disease treatment to India
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

India
Raman-mehta
Sharvil-patel
Torrent-pharmaceuticals
Zydus-lifesciences
Non-alcoholic-steatohepatitis
Non-alcoholic-fatty-liver-disease
Drug-controller-general
Managing-director
Saroglitazar-magnesium
Alcoholic-liver-disease

Torrent and Zydus sign licensing pact for co-marketing Saroglitazar Mg

Torrent and Zydus sign licensing pact for co-marketing Saroglitazar Mg
uniindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniindia.com Daily Mail and Mail on Sunday newspapers.

India
Sharvil-patel
Zydus-lifesciences
Raman-mehta
Torrent-pharmaceuticals-ltd
Saroglitazar-mgnew-delhi
Torrent-pharma
Non-alcoholic-steato-hepatitis
Non-alcoholic-fatty-liver-disease
Saroglitazar-magnesium
Managing-director
Torrent-pharmaceuticals

India's Zydus Q2 profit jumps on strong domestic, US demand

Indian generic drugmaker Zydus Lifesciences Ltd reported a better-than-expected 53.3% jump in quarterly profit on Tuesday, led by the strong sales in the domestic market and the United States..

India
Sharvil-patel
Dhanya-ann-thoppil
Rishika-sadam
Cipla
Zydus-wellness-ltd
Director-sharvil-patel
Nifty-pharma
Markets

Zydus Lifesciences Q2 Results: Firm reports 53% YoY jump in net profit at Rs 801 crore

Revenue from operations rose 9.1% YoY to Rs 4369 crore in Q2FY24 compared to Rs 4006 crore in Q2FY23. On QoQ revenue declined 15%. The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 40.6% YoY to Rs 1146 crore. On QoQ, EBITDA dropped 23.9%.

India
Sharvil-patel
Zydus-lifesciences
Zydus-lifesciences-q2-results
Zydus-lifesciences-q2
Zydus-lifesciences-results
Zydus-lifesciences-q2-earnings

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.